Another strong year for Cordis' (US) international sales
This article was originally published in Clinica
Executive Summary
Cardiology specialist Cordis' (US) international sales increased 44% in fiscal 1995, contributing 62% to the $443.2 million turnover. Even corrected for currency moves, the increase in international sales was 33%, similar to the previous year. Growth was driven by the coronary angioplasty business, the company says. US sales were up 15% compared with the previous year.